Biotech is buzzing: Piper Sandler just spotlighted two cancer-fighting stocks—Olema and Oric Pharmaceuticals—that analysts are calling “Strong Buys.” Olema’s got a potential breakthrough breast cancer drug in the works, while Oric is tackling why some cancers stop responding to treatment. Both have big pharma partners and promising trial results, with analysts predicting up to 80% upside. If you’re into investing with impact, these could be the next big thing in cancer therapy! #Health #BodyHealth #CancerResearch